Endometrial Dedifferentiated Carcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Dedifferentiated Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma [Phase 2]
This Phase 2 trial investigates nivolumab with or without ipilimumab in mismatch repair–deficient (dMMR) recurrent endometrial cancer and is…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
MD Anderson Cancer Center is conducting a study to determine if liquid biopsies and tumor molecular profiling can predict recurrence in vari…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer [Phase 3]
Phase 3 trial evaluating adding pembrolizumab to paclitaxel and carboplatin for stage III-IV or recurrent endometrial cancer.